腫瘍学における人工知能の世界市場レポート 2025年

腫瘍学における人工知能市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR33.9％で76億米ドルに成長します。予測期間の成長は、電子カルテ（EHR）との統合、治療意思決定支援、患者参加と教育、規制支援、標準化におけるアプリケーションの拡大に起因しています。予測期間の主な動向には、ヘルスケアにおける自然言語処理（NLP）の統合、バイオマーカー探索におけるaiの活用、臨床導入における説明可能なaiへの注力、集団健康管理におけるaiの統合、ai開発者とヘルスケアプロバイダー間のコラボレーション、予測分析の進歩などがあります。

がん罹患率の増加は、がん領域におけるAI市場の拡大を推進する主要な要因になると予想されます。がんは、体内の異常細胞の無秩序な増殖と分裂を特徴とする多面的な疾患群です。腫瘍学へのAIの統合は、がん医療に革命をもたらし、より高い精度、個別化、効率性を提供します。例えば、米国を拠点とする任意団体である米国がん協会（American Cancer Society Inc.）の報告書によると、2023年には新たながん患者が180万人から190万人に増加すると推定されています。このように、がん患者の発生が増加していることが、がん領域におけるAI市場の成長を後押ししています。

製薬企業によるクラウドベースのアプリケーションやサービスの利用が拡大していることが、今後、腫瘍学における人工知能（AI）市場の成長を促進すると予想されます。腫瘍学におけるこうしたクラウド・ソリューションの採用は、その多くの利点により着実に増加しています。クラウド・コンピューティングにより、研究者はゲノム、プロテオミクス、メタボロミクス、トランスクリプトミクス、臨床・疫学情報などの広範なデータセットにアクセスして分析することができます。この機能は、精密医療を目指したがん研究を加速させる上で特に有益です。例えば、2024年6月、英国を拠点とする非政府組織AAG IT Servicesは、2022年に調査対象となった組織の89％がストレージとワークロードにマルチクラウドソリューションを採用した一方、単一のパブリッククラウドを使用したのはわずか9％、単一のプライベートクラウドに依存したのは2％であったと報告しています。このように、製薬企業によるクラウドベースのアプリケーションとサービスの採用が増加していることが、がん領域のAI市場を牽引することになりそうです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腫瘍学における人工知能PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の腫瘍学における人工知能市場：成長率分析
• 世界の腫瘍学における人工知能市場の実績：規模と成長, 2019-2024
• 世界の腫瘍学における人工知能市場の予測：規模と成長, 2024-2029, 2034F
• 世界腫瘍学における人工知能総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腫瘍学における人工知能市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェアソリューション
• ハードウェア
• サービス
• 世界の腫瘍学における人工知能市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線治療
• 免疫療法
• その他の治療の種類
• 世界の腫瘍学における人工知能市場がんの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 肺がん
• 前立腺がん
• 大腸がん
• 脳腫瘍
• その他のがんの種類
• 世界の腫瘍学における人工知能市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん検出
• 創薬
• 医薬品開発
• その他の用途
• 世界の腫瘍学における人工知能市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 製薬会社
• 調査機関
• その他のエンドユーザー
• 世界の腫瘍学における人工知能市場、ソフトウェアソリューションのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断ソフトウェア
• 治療計画ソフトウェア
• 患者管理ソフトウェア
• データ分析プラットフォーム
• 世界の腫瘍学における人工知能市場、ハードウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• AI対応画像デバイス
• 高性能コンピューティングシステム
• ウェアラブルヘルスモニター
• 世界の腫瘍学における人工知能市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 統合サービス
• メンテナンスおよびサポートサービス

第7章 地域別・国別分析

• 世界の腫瘍学における人工知能市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腫瘍学における人工知能市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腫瘍学における人工知能市場：競合情勢
• 腫瘍学における人工知能市場：企業プロファイル
  • Azra AI Overview, Products and Services, Strategy and Financial Analysis
  • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• NVIDIA Corporation
• Digital Diagnostics Inc.
• ConcertAI Inc.
• PathAI Inc.
• Median Technologies SA
• Kheiron Medical Technologies Ltd
• Hampton Research Inc.
• Tempus Labs Inc.
• Paige AI Inc.
• Prognos Health Inc.
• Enlitic
• Inspirata Inc.
• Berg LLC
• Proscia Inc.
• Prognos Health Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腫瘍学における人工知能市場2029：新たな機会を提供する国
• 腫瘍学における人工知能市場2029：新たな機会を提供するセグメント
• 腫瘍学における人工知能市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Artificial intelligence in oncology involves the application of AI technologies and techniques to enhance cancer diagnosis, treatment, research, and patient care. The overarching objective is to improve outcomes for cancer patients by utilizing computational methods to identify patterns, predict outcomes, and support evidence-based decision-making throughout the entire spectrum of cancer care.

The key components of artificial intelligence in oncology encompass software solutions, hardware, and services. In the oncology field, software solutions leverage AI to enhance various aspects of cancer diagnosis, treatment, and research. These applications are relevant to different treatment types such as chemotherapy, radiotherapy, and immunotherapy, addressing various cancer types including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, and others. The technology is utilized in applications such as cancer detection, drug discovery, and drug development, serving diverse end-users such as hospitals, diagnostic centers, pharmaceutical companies, research institutes, and others.

The artificial intelligence in oncology market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in oncology market statistics, including artificial intelligence in the oncology industry global market size, regional shares, competitors with artificial intelligence in oncology market share, detailed artificial intelligence in oncology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in oncology industry. This artificial intelligence in oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in oncology market size has grown exponentially in recent years. It will grow from $1.78 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 32.4%. The growth in the historic period can be attributed to rising cancer incidence, data proliferation in healthcare, clinical trial optimization, demand for personalized medicine, efficiency in radiology and pathology.

The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to $7.6 billion in 2029 at a compound annual growth rate (CAGR) of 33.9%. The growth in the forecast period can be attributed to integration with electronic health records (EHR), expanded applications in treatment decision support, patient engagement and education, regulatory support, and standardization. Major trends in the forecast period include integration of natural language processing (NLP) in healthcare, utilization of ai in biomarker discovery, focus on explainable ai for clinical adoption, integration of ai in population health management, collaborations between ai developers and healthcare providers, advancements in predictive analytics.

The growing incidence of cancer cases is anticipated to be a key driver propelling the expansion of the AI in oncology market. Cancer represents a multifaceted group of diseases characterized by the unregulated proliferation and division of abnormal cells within the body. The integration of AI into oncology stands to revolutionize cancer care, offering greater precision, personalization, and efficiency. For example, in 2023, a report from the American Cancer Society Inc., a US-based voluntary health organization, indicated an estimated increase in new cancer cases from 1.8 million to 1.9 million. Thus, the escalating occurrence of cancer cases fuels the growth of the AI in oncology market.

The growing use of cloud-based applications and services by pharmaceutical companies is expected to fuel the growth of artificial intelligence (AI) in the oncology market moving forward. The adoption of these cloud solutions in oncology has been rising steadily due to their many advantages. Cloud computing allows researchers to access and analyze extensive data sets, including genomics, proteomics, metabolomics, transcriptomics, and clinical and epidemiological information. This capability has been particularly beneficial in accelerating cancer research aimed at precision medicine. For example, in June 2024, AAG IT Services, a UK-based non-governmental organization, reported that in 2022, 89% of the organizations surveyed employed multi-cloud solutions for their storage and workloads, while only 9% used a single public cloud and 2% depended on a single private cloud. Thus, the increasing adoption of cloud-based applications and services by pharmaceutical companies is set to drive the AI in oncology market.

Leading companies in the AI in oncology market are concentrating on the development of innovative software, including cloud-based solutions, to enhance their effectiveness and deliver improved outcomes. Cloud-based software plays a pivotal role in AI applications within oncology, offering a scalable, adaptable, and accessible platform for processing and analyzing extensive volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Connected Insights, a novel cloud-based software designed for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights streamlines result interpretation and reporting from various assay types, empowering laboratories to expand their utilization of Next-Generation Sequencing (NGS) and accelerate the clinical reporting turnaround time.

In May 2024, Lunit, a medical solutions company based in South Korea, acquired Volpara Health Technologies for $193 million. The goal of this acquisition is to establish a strong partnership in the cancer diagnostics sector, especially within the U.S. market. By leveraging their combined strengths, Lunit aims to enhance its AI-driven solutions for early cancer detection and improve patient care. Volpara Health Technologies is a healthcare software company located in New Zealand that develops and sells tools for the detection and diagnosis of breast cancer.

Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence in oncology market consists of revenues earned by entities by providing services such as surgery, targeted therapy, and stem cell transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the oncology market also includes sales of edge devices, storage devices, field-programmable gate arrays (FPGA), and tensor processing units (TPU). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software Solutions; Hardware; Services
• 2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types
• 3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types
• 4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications
• 5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users
• Subsegments:
• 1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms
• 2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors
• 3) By Services: Consulting Services; Integration Services; Maintenance And Support Services
• Companies Mentioned: Azra AI; IBM Corporation; Siemens Healthcare GmbH; Intel Corporation; GE HealthCare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Oncology Market Characteristics

3. Artificial Intelligence In Oncology Market Trends And Strategies

4. Artificial Intelligence In Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence In Oncology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Oncology Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Oncology Total Addressable Market (TAM)

6. Artificial Intelligence In Oncology Market Segmentation

• 6.1. Global Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Solutions
• Hardware
• Services
• 6.2. Global Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Other Treatment Types
• 6.3. Global Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Other Cancer Types
• 6.4. Global Artificial Intelligence In Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Detection
• Drug Discovery
• Drug Development
• Other Applications
• 6.5. Global Artificial Intelligence In Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Pharmaceutical Companies
• Research Institutes
• Other End Users
• 6.6. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Software
• Treatment Planning Software
• Patient Management Software
• Data Analytics Platforms
• 6.7. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Enabled Imaging Devices
• High-Performance Computing Systems
• Wearable Health Monitors
• 6.8. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Integration Services
• Maintenance And Support Services

7. Artificial Intelligence In Oncology Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Oncology Market

• 8.1. Asia-Pacific Artificial Intelligence In Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Oncology Market

• 9.1. China Artificial Intelligence In Oncology Market Overview
• 9.2. China Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Oncology Market

• 10.1. India Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Oncology Market

• 11.1. Japan Artificial Intelligence In Oncology Market Overview
• 11.2. Japan Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Oncology Market

• 12.1. Australia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Oncology Market

• 13.1. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Oncology Market

• 14.1. South Korea Artificial Intelligence In Oncology Market Overview
• 14.2. South Korea Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Oncology Market

• 15.1. Western Europe Artificial Intelligence In Oncology Market Overview
• 15.2. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Oncology Market

• 16.1. UK Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Oncology Market

• 17.1. Germany Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Oncology Market

• 18.1. France Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Oncology Market

• 19.1. Italy Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Oncology Market

• 20.1. Spain Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Oncology Market

• 21.1. Eastern Europe Artificial Intelligence In Oncology Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Oncology Market

• 22.1. Russia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Oncology Market

• 23.1. North America Artificial Intelligence In Oncology Market Overview
• 23.2. North America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Oncology Market

• 24.1. USA Artificial Intelligence In Oncology Market Overview
• 24.2. USA Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Oncology Market

• 25.1. Canada Artificial Intelligence In Oncology Market Overview
• 25.2. Canada Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Oncology Market

• 26.1. South America Artificial Intelligence In Oncology Market Overview
• 26.2. South America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Oncology Market

• 27.1. Brazil Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Oncology Market

• 28.1. Middle East Artificial Intelligence In Oncology Market Overview
• 28.2. Middle East Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Oncology Market

• 29.1. Africa Artificial Intelligence In Oncology Market Overview
• 29.2. Africa Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Oncology Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Oncology Market Competitive Landscape
• 30.2. Artificial Intelligence In Oncology Market Company Profiles
  • 30.2.1. Azra AI Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Oncology Market Other Major And Innovative Companies

• 31.1. NVIDIA Corporation
• 31.2. Digital Diagnostics Inc.
• 31.3. ConcertAI Inc.
• 31.4. PathAI Inc.
• 31.5. Median Technologies SA
• 31.6. Kheiron Medical Technologies Ltd
• 31.7. Hampton Research Inc.
• 31.8. Tempus Labs Inc.
• 31.9. Paige AI Inc.
• 31.10. Prognos Health Inc.
• 31.11. Enlitic
• 31.12. Inspirata Inc.
• 31.13. Berg LLC
• 31.14. Proscia Inc.
• 31.15. Prognos Health Inc.

32. Global Artificial Intelligence In Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Oncology Market

34. Recent Developments In The Artificial Intelligence In Oncology Market

35. Artificial Intelligence In Oncology Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Oncology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Oncology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Oncology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer